Lyophilized human anti-Rhesus immunoglobulin RhO(D): description, application and production.
Lyophilized human anti-Rhesus immunoglobulin RhO(D) is a drug that is used for the prevention and treatment of hemolytic disease of newborns. This condition can occur if the mother and baby have different blood types or different Rh factors and the fetal blood enters the mother's bloodstream. In such cases, the mother's immune system begins to produce antibodies against the baby's blood, which can lead to the destruction of red blood cells and other serious complications. The use of lyophilized human anti-Rhesus immunoglobulin RhO(D) helps prevent the development of hemolytic disease of newborns.
The drug is produced in Russia by the Hematologist company and belongs to the group of immunoglobulins. It contains antibodies to the Rh factor obtained from the plasma of blood donors. The dosage form is a substance in the form of a powder, which before use is dissolved in a special solvent and administered intravenously.
Lyophilized human anti-Rhesus immunoglobulin RhO(D) is a safe and effective way to prevent and treat hemolytic disease of newborns. However, like any medical drug, it has a number of contraindications and limitations in use. Before using it, you must consult your doctor and strictly follow its prescription.
Thus, lyophilized human anti-Rhesus immunoglobulin RhO(D) is an important drug that helps prevent serious complications in newborns. Its production is carried out in Russia, and the quality and safety of the drug is controlled by relevant organizations. However, it must be remembered that self-medication can be dangerous, so you should always consult your doctor before using this drug.